Bridgeway Capital Management’s Genocea Biosciences, Inc. GNCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-18,875
| Closed | -$220K | – | 1473 |
|
|
2017
Q3 | $220K | Hold |
18,875
| – | – | ﹤0.01% | 1266 |
|
|
2017
Q2 | $788K | Hold |
18,875
| – | – | 0.01% | 920 |
|
|
2017
Q1 | $920K | Buy |
18,875
+4,000
| +27% | +$195K | 0.01% | 844 |
|
|
2016
Q4 | $490K | Hold |
14,875
| – | – | 0.01% | 1096 |
|
|
2016
Q3 | $609K | Buy |
14,875
+3,750
| +34% | +$154K | 0.01% | 1001 |
|
|
2016
Q2 | $365K | Sell |
11,125
-4,900
| -31% | -$161K | 0.01% | 1168 |
|
|
2016
Q1 | $992K | Buy |
16,025
+8,000
| +100% | +$495K | 0.02% | 778 |
|
|
2015
Q4 | $338K | Buy |
8,025
+4,900
| +157% | +$206K | 0.01% | 1177 |
|
|
2015
Q3 | $171K | Hold |
3,125
| – | – | ﹤0.01% | 1332 |
|
|
2015
Q2 | $343K | Hold |
3,125
| – | – | 0.01% | 1209 |
|
|
2015
Q1 | $297K | Sell |
3,125
-627
| -17% | -$59.6K | 0.01% | 1262 |
|
|
2014
Q4 | $210K | Buy |
3,752
+1,500
| +67% | +$84K | ﹤0.01% | 1299 |
|
|
2014
Q3 | $163K | Buy |
+2,252
| New | +$163K | ﹤0.01% | 1364 |
|